Aduro Biotech (ADRO) Reports Q1 Loss of $0.45

Aduro Biotech (NASDAQ: ADRO) reported Q1 EPS of ($0.45), versus ($39.97) reported last year.

For earnings history and earnings-related data on Aduro Biotech (ADRO) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22
• Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)